CD8A and COVID-19: Oberhardt V et al. [83] found that the first dose of COVID-19 vaccines is associated with inducing a significantly higher level of anti-spike IgG protein, resulting in a proportionately higher number of naive and transitional B cells, as well as functional spike-specific CD8+ T cells, which is parallel to findings observed by Singh RB et al. [71].